Top Suppliers:I want be here




50-22-6

50-22-6 structure
50-22-6 structure
  • Name: Corticosterone
  • Chemical Name: corticosterone
  • CAS Number: 50-22-6
  • Molecular Formula: C21H30O4
  • Molecular Weight: 346.461
  • Catalog: API Antibiotics Other antibiotics
  • Create Date: 2018-02-09 08:00:00
  • Modify Date: 2025-08-24 21:38:04
  • Corticosterone is an adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid.

Name corticosterone
Synonyms Pregn-4-ene-3,20-dione, 11β,21-dihydroxy-
CORTICOSTERONE
Pregn-4-ene-3,20-dione, 11β, 21-dihydroxy-
Pregn-4-ene-3,20-dione, 11,21-dihydroxy-, (11β)-
EINECS 200-019-6
4-Pregnene-11b,21-diol-3,20-dione
11b,21-Dihydroxy-4-pregnene-3,20-dione
MFCD00037715
(11β)-11,21-Dihydroxypregn-4-ene-3,20-dione
Pregn-4-ene-3,20-dione, 11,21-dihydroxy-, (11-β)- (9CI)
11b,21-Dihydroxyprogesterone
(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
(11b)-11,21-Dihydroxypregn-4-ene-3,20-dione
11b,21-Dihydroxypregn-4-ene-3,20-dione
Pregn-4-ene-3,20-dione, 11-β,21-dihydroxy-
4-08-00-02907 (Beilstein Handbook Reference)
4-Pregnene-11β,21-diol-3,20-dione
Density 1.2±0.1 g/cm3
Boiling Point 529.2±50.0 °C at 760 mmHg
Melting Point 179-183 °C(lit.)
Molecular Formula C21H30O4
Molecular Weight 346.461
Flash Point 288.0±26.6 °C
Exact Mass 346.214417
PSA 74.60000
LogP 1.76
Vapour Pressure 0.0±3.2 mmHg at 25°C
Index of Refraction 1.576
Storage condition Store at RT
Stability Stable, but light sensitive. Incompatible with strong oxidizing agents.

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GM7650000
CHEMICAL NAME :
Corticosterone
CAS REGISTRY NUMBER :
50-22-6
BEILSTEIN REFERENCE NO. :
2339601
LAST UPDATED :
199703
DATA ITEMS CITED :
13
MOLECULAR FORMULA :
C21-H30-O4
MOLECULAR WEIGHT :
346.51
WISWESSER LINE NOTATION :
L E5 B666 OV MUTJ A1 CQ E1 FV1Q

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
14 mg/kg
SEX/DURATION :
female 19-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - respiratory system Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
525 mg/kg
SEX/DURATION :
female 12-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - endocrine system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
500 mg/kg
SEX/DURATION :
female 8-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
84 mg/kg
SEX/DURATION :
female 16-22 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - behavioral
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
1472 mg/kg
SEX/DURATION :
female 11-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
400 mg/kg
SEX/DURATION :
female 11-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
100 mg/kg
SEX/DURATION :
female 13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
400 mg/kg
SEX/DURATION :
female 11-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
40 mg/kg
SEX/DURATION :
female 11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
80 mg/kg
SEX/DURATION :
female 11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Bird - chicken Embryo
DOSE/DURATION :
1500 pmol/L
REFERENCE :
NATUAS Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869- Volume(issue)/page/year: 257,804,1975
Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H317
Precautionary Statements P280
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Faceshields;Gloves
Hazard Codes Xi,N,Xn,T
Risk Phrases R43
Safety Phrases S36
RIDADR 2811.0
WGK Germany 3
RTECS GM7650000
Hazard Class 6.1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.